Based on the CSL LTD SPON.ADR 2 stock forecast from 0 analysts, the average analyst target price for CSL LTD SPON.ADR 2 is not available over the next 12 months. CSL LTD SPON.ADR 2’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CSL LTD SPON.ADR 2 is Slightly Bullish , which is based on 6 positive signals and 4 negative signals. At the last closing, CSL LTD SPON.ADR 2’s stock price was EUR 81.50. CSL LTD SPON.ADR 2’s stock price has changed by -2.98% over the past week, -0.61% over the past month and -5.23% over the last year.
No recent analyst target price found for CSL LTD SPON.ADR 2
No recent average analyst rating found for CSL LTD SPON.ADR 2
Company Overview CSL LTD SPON.ADR 2
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Read Less
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL...Read More
Frequently Asked Questions About CSL LTD SPON.ADR 2 (CSJA:F) Stock
Stock Target Advisor's fundamental analysis for CSL LTD SPON.ADR 2's stock is Slightly Bullish .
CSJA:F stock's dividend yield is 1.41%.
Our analysis grades CSJA:F stock's dividend yield at F. This means that CSJA:F stock's dividend yield is above 35% of the stocks in the Biotechnology sector in the F exchange.
Based on this CSJA:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on CSJA:F's stock to indicate what its average analyst target is.
CSJA:F stock's Price/Earning ratio is 33.27.
Our analysis grades CSJA:F stock's Price / Earning ratio at F. This means that CSJA:F stock's Price/Earning ratio is above 68% of the stocks in the Biotechnology sector in the F exchange.
Based on this CSJA:F may be a overvalued for its sector.
The last closing price of CSJA:F's stock was EUR 81.50.
The most recent market capitalization for CSJA:F is EUR 84.96B.
Unfortunately we do not have enough analyst data on CSJA:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CSL LTD SPON.ADR 2's stock.
As per our most recent records CSL LTD SPON.ADR 2 has 32,698 Employees.
CSL LTD SPON.ADR 2's registered address is 655 Elizabeth Street, Melbourne, VIC, Australia, 3000.
You can get more information about it from CSL LTD SPON.ADR 2's website at https://www.csl.com.au.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About CSL LTD SPON.ADR 2 (CSJA:F) Stock
Stock Target Advisor's fundamental analysis for CSL LTD SPON.ADR 2's stock is Slightly Bullish .
CSJA:F stock's dividend yield is 1.41%.
Our analysis grades CSJA:F stock's dividend yield at F. This means that CSJA:F stock's dividend yield is above 35% of the stocks in the Biotechnology sector in the F exchange.
Based on this CSJA:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on CSJA:F's stock to indicate what its average analyst target is.
CSJA:F stock's Price/Earning ratio is 33.27.
Our analysis grades CSJA:F stock's Price / Earning ratio at F. This means that CSJA:F stock's Price/Earning ratio is above 68% of the stocks in the Biotechnology sector in the F exchange.
Based on this CSJA:F may be a overvalued for its sector.
The last closing price of CSJA:F's stock was EUR 81.50.
The most recent market capitalization for CSJA:F is EUR 84.96B.
Unfortunately we do not have enough analyst data on CSJA:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CSL LTD SPON.ADR 2's stock.
As per our most recent records CSL LTD SPON.ADR 2 has 32,698 Employees.
CSL LTD SPON.ADR 2's registered address is 655 Elizabeth Street, Melbourne, VIC, Australia, 3000.
You can get more information about it from CSL LTD SPON.ADR 2's website at https://www.csl.com.au.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CSJA:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
